Bio-Techne Stock Forecast & Price Target
Bio-Techne Price Target 2026
The Quantum Forecast sees a price target of $70.83 (−1.5%) for Bio-Techne in about one month (by Dec 11, 2026).
Quantum Forecast price targets by time frame, calculated from the current price of $71.89. Click to see the forecast in the chart.
Bio-Techne Forecast for Today and Tomorrow
In the short term, the Quantum Forecast sees Bio-Techne at $72.01 (+0.15%) today around 9:45 AM ET and at $72.31 (+0.57%) tomorrow around 4:15 AM ET. It is based on prices from the current trading day and the past week. Short-term forecast in the chart
Bio-Techne Stock 2026: Price Performance
Bio-Techne stock has gained 22.2% since the start of 2026 and currently trades at $71.89 (as of Nov 12, 2026). Over the same period the S&P 500 is up 10.5%, putting the stock 11.7 percentage points ahead of the index. Over the past 52 weeks the price ranged between $43.07 and $73.61; it is currently 2.3% below its high of Nov 11, 2026.
Bio-Techne Forecast 2027
Over a horizon of roughly 10 months (until about Sep 2027), the Quantum Forecast sees a price target of $79.50 for Bio-Techne – +10.6% from today. The range band runs from $49.80 – $109.20: the further ahead the forecast looks, the greater the uncertainty. See the long-term forecast in the chart
Community Forecast for Bio-Techne
There are no user forecasts for Bio-Techne yet – be the first to make one.
Make your own forecastAbout Bio-Techne
Bio-Techne Corporation supplies reagents, instruments and diagnostic products for life sciences research and clinical use. Headquartered in Minneapolis, Minnesota, the company grew from Techne, founded in 1976, and its subsidiary R&D Systems. Its Protein Sciences segment provides antibodies, proteins, cytokines and immunoassays, as well as instruments for protein analysis such as Simple Western systems from ProteinSimple. The Diagnostics and Spatial Biology segment includes RNAscope technology for tissue analysis and molecular diagnostic tests.
Customers are academic and government research institutions, biopharmaceutical companies developing drugs and cell and gene therapies, and clinical diagnostics laboratories in North America, Europe, China and other regions. Revenue relies heavily on recurring consumables, but demand is sensitive to biotech funding, pharma research budgets and U.S. government funding for agencies such as the National Institutes of Health. Growth areas include cell therapy manufacturing reagents and spatial biology. Bio-Techne trades on the Nasdaq under the ticker TECH and belongs to the S&P 500.
The current price of Bio-Techne stock is $71.89 (−0.84% vs. the previous close). In today's trading the high was $72.79 and the low $71.18.
How the Quantum Forecast works
Research from quantum physics. The models are the result of several years of research at the Max Planck Institute of Quantum Optics and LMU Munich and were transferred to the stock market.
Spectra and correlations. Frequency spectra are calculated from current prices, and the relationships between price swings and volatility are analyzed. This produces the forecast and the risk assessment.
Detecting herd behavior. Models of phase transitions from statistical physics describe when investors collectively fall into panic or euphoria – an early sign of possible crash situations.
Swarm intelligence. User forecasts are checked once their time frame has expired and feed into the model, weighted by their hit rate.
The range band shows the typical fluctuation around the forecast. More on quantum physics & swarm intelligence
Frequently Asked Questions about Bio-Techne Stock
What is the Bio-Techne stock forecast?
The Quantum Forecast expects Bio-Techne to reach $70.83 in about one month (by Dec 11, 2026), a change of −1.5% from the current price of $71.89. Over roughly 10 months (by Sep 2027) the price target is $79.50 (+10.6%).
What is the Bio-Techne stock price target?
Quantum Forecast price targets by time frame: 1 month $70.83 (−1.5%), 2 months $66.88 (−7.0%), 6 months $75.81 (+5.5%), 10 months $79.50 (+10.6%). The range band shows the typical fluctuation around these targets.
Will Bio-Techne stock go up or down?
In the short term the Quantum Forecast points down (−1.5% over one month). No forecast is certain – it is based on historical prices and statistical analysis.
How is the Quantum Forecast computed?
Trends, frequency spectra and correlations are calculated from the price history using methods from quantum physics; user opinions are added as well (swarm intelligence). The range band reflects the volatility of the security and widens with the time horizon.
Can I make my own forecast for Bio-Techne?
Yes – in the Forecast League you pick long or short and a price target for 1 day up to 6 months. Forecasts are scored automatically when they expire; correct calls earn points and a spot on the leaderboard.